Sandoz Group AG (SDZXF)

Market Cap	27.11B
Revenue (ttm)	10.59B
Net Income (ttm)	227.00M
Shares Out	n/a
EPS (ttm)	0.52
PE Ratio	119.43
Forward PE	17.39
Dividend	0.73 (1.18%)
Ex-Dividend Date	Apr 17, 2025

Volume	316
Average Volume	1,380
Open	62.16
Previous Close	n/a
Day's Range	62.16 - 62.16
52-Week Range	36.68 - 62.16
Beta	n/a
RSI	74.94
Earnings Date	Aug 7, 2025

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1886
• Employees: 22,049
• Stock Exchange: OTCMKTS
• Ticker Symbol: SDZXF